Purchase Order 75N93023P01157

Award Date 8/30/23
Potential Completion Date 12/31/23
Potential Value $146K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $59,850 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute. The contract is for the delivery of 150 clinical whole genome sequencing services, with a completion date of September 30, 2024. Broad Clinical Laboratories is a specialized healthcare services provider that offers genetic testing and clinical genome sequencing to federal agencies, particularly the Department...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $240,622 firm fixed price purchase order to Baylor College of Medicine. The contract calls for whole genome sequencing of 200 samples to support NIAID's research efforts. Specifically, the contractor will perform clinical whole genome sequencing, sample processing, and data analysis on samples provided by NIAID. The sequencing must meet CLIA and CAP...
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, to provide whole genome sequencing of sickle cell disease samples. The contract has a potential value of $187,500.00 and a completion date of July 6, 2023. The Broad Institute has extensive experience providing genomics and data services to the...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
This $202,500 firm-fixed price purchase order was awarded to The Broad Institute, Inc. by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for whole genome sequencing of sickle cell patient blood samples, with a completion date of September 21, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like NIH, CDC, and DoD to provide...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for $105,341.32. The order includes various sequencing products such as the NovaSeq 6000 S2 Reagent Kit, NovaSeq XP 2-Lane Kit, MiSeq Reagent Kit V2, and Nextera XT DNA Library Preparation Kit to support life science research, applied...
The National Heart, Lung, and Blood Institute of the National Institutes of Health within the Department of Health and Human Services awarded a $391,500 purchase order to The Broad Institute, Inc. for whole genome sequencing services related to sickle cell disease. Per the pre-solicitation notice, the Broad Institute will sequence the DNA of 5,000 sickle cell patients to identify genetic factors influencing clinical outcomes. Performance will occur in Cambridge, Massachusetts over a 24-month...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to provide genomic sequencing and analysis services in support of NIH research programs focused on infectious diseases and immunology. Place of performance is in Cambridge, Massachusetts. No subcontractors or set aside designations were identified.

Generated 12/20/23, 5:13 PM